Edition:
India

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

15.91USD
1:30am IST
Change (% chg)

$0.08 (+0.51%)
Prev Close
$15.83
Open
$15.85
Day's High
$16.39
Day's Low
$15.78
Volume
33,818
Avg. Vol
94,148
52-wk High
$26.74
52-wk Low
$11.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -1.606
Sep '17 0.00 -0.564
Jun '17 0.00 -0.472
Mar '17 0.00 -0.419
FY 2016 Dec '16 0.00 -0.361
Sep '16 0.00 -0.415
Jun '16 0.00 -0.423
Mar '16 0.00 -0.226
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 27.17 43.00 18.13 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.50 -0.45 -0.53 --
Quarter Ending Sep-18 3 -0.53 -0.45 -0.61 --
Year Ending Dec-18 3 -2.06 -1.89 -2.19 --
Year Ending Dec-19 4 -2.58 -1.93 -3.38 --
LT Growth Rate (%) 1 -91.20 -91.20 -91.20 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % -98.82 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kala Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.02 -14.09 44 --
13 Week -- -- -- --
26 Week -- -- -- --
52 Week -- -- -- --
YTD -- -- -- --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.24%
# of Holders: 96
Total Shares Held: 20,441,112
3 Mo. Net Change: 332,422
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 7
# Reduced Positions: 4
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.